Physician profile
Mona Bhan
NPI 1679571798
$1,795.95
in general payments reported to CMS, 2019-2025
16 companies · $334 in 2025
The $334 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2020: $14.10 · 2021: $187 · 2022: $366 · 2023: $102 · 2024: $561 · 2025: $334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $997.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $996.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $377.24 | 2022-2025 | Xifaxan, Trulance |
| Abbvie INC. | $296.26 | 2022-2025 | Durysta |
| Amgen INC. | $275.20 | 2024-2025 | Tepezza |
| Allergan, INC. | $218.69 | 2020-2022 | |
| Alcon Vision LLC | $123.83 | 2025 | Rocklatan, Rhopressa |
| Biogen, INC. | $100.00 | 2022 | |
| Aerie Pharmaceuticals, INC. | $97.63 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $94.63 | 2024-2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $63.88 | 2019 | |
| Mallinckrodt Enterprises LLC | $29.33 | 2019 | |
| Bausch & Lomb Americas INC. | $23.49 | 2022 | |
| Oyster Point Pharma, INC. | $23.22 | 2023 | Tyrvaya |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $21.68 | 2019 | |
| Kala Pharmaceuticals, INC. | $19.27 | 2019 | |
| Novartis Pharmaceuticals Corporation | $16.68 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ocular Therapeutix, INC. | $14.92 | 2025 | Dextenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mona Bhan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.